Congenital Hypothyroidism (CHT)
7 Sept 2026 · 2 min read

On this page4 sections
Congenital hypothyroidism (CHT) is a condition present from birth caused by a partial or complete loss of thyroid function. The thyroid gland produces crucial hormones that regulate:
Physical growth and development.
Early brain development.
Metabolism (how the body converts food into energy).
CHT occurs when the thyroid gland either fails to form during fetal development or does not function correctly at birth.
Diagnosis and Prevalence
Screening: Every newborn baby is routinely tested for CHT via the newborn blood spot test (heel prick screening) within the first few days of life.
Prevalence: Approximately 1 in every 3,500 babies born in Ireland is diagnosed with the condition.
Genetic Factor: Most cases occur spontaneously in families with no prior history of the condition.
Causes of CHT
Understanding the exact cause is vital for long-term care. A specialized scan of the infant's thyroid gland is performed shortly after diagnosis to identify the root cause, which typically falls into two categories:
Structural Issues: The baby is born with a severely underdeveloped thyroid gland, a misplaced gland, or no thyroid gland at all.
Functional Issues (Rare/Atypical): The baby possesses a thyroid gland, but cannot produce enough thyroxine—the key hormone responsible for healthy growth and brain maturation. These cases often require genetic testing and are more likely to run in families.
Treatment and Management
Early detection via newborn screening allows treatment to begin immediately, entirely preventing the severe learning difficulties and developmental delays associated with untreated CHT.
Thyroxine Replacement: Treatment consists of a daily dose of synthetic thyroxine hormone. If started within the first month of life, the baby will typically grow and develop completely normally.
Dosage Adjustments: As the child grows, their thyroxine dose must be continuously adjusted based on routine blood tests.
Duration: For the vast majority of children, treatment is lifelong. However, a small number of children with temporary forms may have their cases reviewed around age 2 to 3 to determine if they can safely stop medication. This must only ever be done under strict medical supervision.
Continuity of Care: Children attend regular check-ups with a consultant paediatrician throughout childhood and adolescence. Once they are fully grown, their long-term monitoring and care are transitioned to their GP.
Disclaimer
The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.
